Predicting hepatocellular carcinoma: A new non-invasive model based on shear wave elastography.

Background: Integrating conventional ultrasound features with 2D shear wave elastography (2D-SWE) can potentially enhance preoperative hepatocellular carcinoma (HCC) predictions.
Aim: To develop a 2D-SWE-based predictive model for preoperative identification of HCC.
Methods: A retrospective analysis of 884 patients who underwent liver resection and pathology evaluation from February 2021 to August 2023 was conducted at the Oriental Hepatobiliary Surgery Hospital. The patients were divided into the modeling group ( n = 720) and the control group ( n = 164). The study included conventional ultrasound, 2D-SWE, and preoperative laboratory tests. Multiple logistic regression was used to identify independent predictive factors for malignant liver lesions, which were then depicted as nomograms.
Results: In the modeling group analysis, maximal elasticity (Emax) of tumors and their peripheries, platelet count, cirrhosis, and blood flow were independent risk indicators for malignancies. These factors yielded an area under the curve of 0.77 (95% confidence interval: 0.73-0.81) with 84% sensitivity and 61% specificity. The model demonstrated good calibration in both the construction and validation cohorts, as shown by the calibration graph and Hosmer-Lemeshow test ( P = 0.683 and P = 0.658, respectively). Additionally, the mean elasticity (Emean) of the tumor periphery was identified as a risk factor for microvascular invasion (MVI) in malignant liver tumors ( P = 0.003). Patients receiving antiviral treatment differed significantly in platelet count ( P = 0.002), Emax of tumors ( P = 0.033), Emean of tumors ( P = 0.042), Emax at tumor periphery ( P < 0.001), and Emean at tumor periphery ( P = 0.003).
Conclusion: 2D-SWE's hardness value serves as a valuable marker for enhancing the preoperative diagnosis of malignant liver lesions, correlating significantly with MVI and antiviral treatment efficacy.
Competing Interests: Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
(©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)